Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip P Chamberlain

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Nature|July 2, 2015
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDSJan Krönke, Emma C Fink, Paul W Hollenbach, et al.
Nature|June 25, 2016
A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligaseMary E Matyskiela, Gang Lu, Takumi Ito, et al.
Blood Cancer Discovery|May 24, 2021
Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignanciesAline Renneville, Jessica A Gasser, Daniel E Grinshpun, et al.
Journal of Medicinal Chemistry|October 7, 2025
Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760Hunter P Shunatona, Natalie Holmberg Douglas, Jayce Rhodes, et al.
Journal of Medicinal Chemistry|October 10, 2017
The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic ScreenJennifer R Riggs, Mark Nagy, Jan Elsner, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Nature|July 2, 2015
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDSJan Krönke, Emma C Fink, Paul W Hollenbach, et al.
Nature|June 25, 2016
A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligaseMary E Matyskiela, Gang Lu, Takumi Ito, et al.
Blood Cancer Discovery|May 24, 2021
Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignanciesAline Renneville, Jessica A Gasser, Daniel E Grinshpun, et al.
Journal of Medicinal Chemistry|October 7, 2025
Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760Hunter P Shunatona, Natalie Holmberg Douglas, Jayce Rhodes, et al.
Journal of Medicinal Chemistry|October 10, 2017
The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic ScreenJennifer R Riggs, Mark Nagy, Jan Elsner, et al.
Pageof 3